Clinical Trials Browser

Phase 1 × Hematologic Diseases × fludarabine × Clear all

NCT05755854 2023-09-22

Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors

Phase 1 Unknown

Hematologic Diseases

NCT02660281 2021-11-03

HaploOnly

Phase 1 Completed

LymphoidMyeloidPlasma cell

Hematologic Diseases, Lymphoma, Multiple Myeloma, Primary Myelofibrosis